Therapeutic Goods Act 1989 - Determination under subsection 19A(3) (26/08/1997)
1Therapeutic Goods Act 1989 - Determination under subsection 19A(3) (26/08/1997)
Start here
Get a plain-English read of 1
Turn the raw legal text into a practical explanation grounded in Therapeutic Goods Act 1989 - Determination under subsection 19A(3) (26/08/1997).
meta-content-style-type: text/css meta-content-type: application/xhtml+xml; charset=utf-8 meta-generator: Aspose.Words for .NET 20.2 title: COMMONWEALTH OF AUSTRALIA
?xml version="1.0" encoding="utf-8" standalone="no"?>
COMMONWEALTH OF AUSTRALIA
THERAPEUTIC GOODS ACT 1989
SUBSECTION 19A(3) DETERMINATION
Pursuant to my powers under subsection 19A(3) of the Therapeutic Goods Act 1989, I, ANDREW PODGER, Secretary to the Department of Health and Family Services, specify France as the foreign country for the purposes of the exercise of my powers under subsection 19A(1) of the said Act in relation to Stamaril® Yellow Fever Vaccine manufactured by Pasteur Mérieux Sérums and Vaccins in France.
Dated this twenty sixth day of August 1997
ANDREW PODGER
Secretary
Department of Health and Family Services